165 related articles for article (PubMed ID: 25615281)
1. Novel recurrent mutations in ethanolamine kinase 1 (ETNK1) gene in systemic mastocytosis with eosinophilia and chronic myelomonocytic leukemia.
Lasho TL; Finke CM; Zblewski D; Patnaik M; Ketterling RP; Chen D; Hanson CA; Tefferi A; Pardanani A
Blood Cancer J; 2015 Jan; 5(1):e275. PubMed ID: 25615281
[TBL] [Abstract][Full Text] [Related]
2. Recurrent ETNK1 mutations in atypical chronic myeloid leukemia.
Gambacorti-Passerini CB; Donadoni C; Parmiani A; Pirola A; Redaelli S; Signore G; Piazza V; Malcovati L; Fontana D; Spinelli R; Magistroni V; Gaipa G; Peronaci M; Morotti A; Panuzzo C; Saglio G; Usala E; Kim DW; Rea D; Zervakis K; Viniou N; Symeonidis A; Becker H; Boultwood J; Campiotti L; Carrabba M; Elli E; Bignell GR; Papaemmanuil E; Campbell PJ; Cazzola M; Piazza R
Blood; 2015 Jan; 125(3):499-503. PubMed ID: 25343957
[TBL] [Abstract][Full Text] [Related]
3. A comparison of clinical and molecular characteristics of patients with systemic mastocytosis with chronic myelomonocytic leukemia to CMML alone.
Patnaik MM; Rangit Vallapureddy ; Lasho TL; Hoversten KP; Finke CM; Ketterling RP; Hanson CA; Gangat N; Tefferi A; Pardanani A
Leukemia; 2018 Aug; 32(8):1850-1856. PubMed ID: 29712989
[No Abstract] [Full Text] [Related]
4. Systemic mastocytosis associated with chronic idiopathic myelofibrosis: a distinct subtype of systemic mastocytosis associated with a [corrected] clonal hematological non-mast [corrected] cell lineage disorder carrying the activating point mutations KITD816V and JAK2V617F.
Sotlar K; Bache A; Stellmacher F; Bültmann B; Valent P; Horny HP
J Mol Diagn; 2008 Jan; 10(1):58-66. PubMed ID: 18165278
[TBL] [Abstract][Full Text] [Related]
5. A variant c-KIT mutation, D816H, fundamental to the sequential development of an ovarian mixed germ cell tumor and systemic mastocytosis with chronic myelomonocytic leukemia.
Mitchell SG; Bunting ST; Saxe D; Olson T; Keller FG
Pediatr Blood Cancer; 2017 Apr; 64(4):. PubMed ID: 27781377
[TBL] [Abstract][Full Text] [Related]
6. Detection of c-kit point mutation Asp-816 --> Val in microdissected pooled single mast cells and leukemic cells in a patient with systemic mastocytosis and concomitant chronic myelomonocytic leukemia.
Sotlar K; Fridrich C; Mall A; Jaussi R; Bültmann B; Valent P; Horny HP
Leuk Res; 2002 Nov; 26(11):979-84. PubMed ID: 12363464
[TBL] [Abstract][Full Text] [Related]
7. Systemic mastocytosis with associated clonal hematological non-mast-cell lineage disease: analysis of clinicopathologic features and activating c-kit mutations.
Pullarkat VA; Bueso-Ramos C; Lai R; Kroft S; Wilson CS; Pullarkat ST; Bu X; Thein M; Lee M; Brynes RK
Am J Hematol; 2003 May; 73(1):12-7. PubMed ID: 12701114
[TBL] [Abstract][Full Text] [Related]
8. Mutations of ETNK1 in aCML and CMML.
Kosmider O
Blood; 2015 Jan; 125(3):422-3. PubMed ID: 25593331
[No Abstract] [Full Text] [Related]
9. Variable presence of KITD816V in clonal haematological non-mast cell lineage diseases associated with systemic mastocytosis (SM-AHNMD).
Sotlar K; Colak S; Bache A; Berezowska S; Krokowski M; Bültmann B; Valent P; Horny HP
J Pathol; 2010 Apr; 220(5):586-95. PubMed ID: 20112369
[TBL] [Abstract][Full Text] [Related]
10. A case of chronic myelomonocytic leukemia with severe eosinophilia having t(5;12)(q31;p13) with t(1;7)(q10;p10).
Kim M; Lim J; Lee A; Park G; Kim Y; Han K; Kang CS; Kim YJ; Song JS
Acta Haematol; 2005; 114(2):104-7. PubMed ID: 16103634
[TBL] [Abstract][Full Text] [Related]
11. Prognostically relevant breakdown of 123 patients with systemic mastocytosis associated with other myeloid malignancies.
Pardanani A; Lim KH; Lasho TL; Finke C; McClure RF; Li CY; Tefferi A
Blood; 2009 Oct; 114(18):3769-72. PubMed ID: 19713463
[TBL] [Abstract][Full Text] [Related]
12. Systemic mastocytosis in the elderly.
Butterfield JH; Weiler CR
Am J Hematol; 2013 May; 88(5):406-8. PubMed ID: 23436294
[TBL] [Abstract][Full Text] [Related]
13. Age-related mutations and chronic myelomonocytic leukemia.
Mason CC; Khorashad JS; Tantravahi SK; Kelley TW; Zabriskie MS; Yan D; Pomicter AD; Reynolds KR; Eiring AM; Kronenberg Z; Sherman RL; Tyner JW; Dalley BK; Dao KH; Yandell M; Druker BJ; Gotlib J; O'Hare T; Deininger MW
Leukemia; 2016 Apr; 30(4):906-13. PubMed ID: 26648538
[TBL] [Abstract][Full Text] [Related]
14. RAS mutations contribute to evolution of chronic myelomonocytic leukemia to the proliferative variant.
Ricci C; Fermo E; Corti S; Molteni M; Faricciotti A; Cortelezzi A; Lambertenghi Deliliers G; Beran M; Onida F
Clin Cancer Res; 2010 Apr; 16(8):2246-56. PubMed ID: 20371679
[TBL] [Abstract][Full Text] [Related]
15. Eosinophilia in systemic mastocytosis: clinical and molecular correlates and prognostic significance.
Böhm A; Födinger M; Wimazal F; Haas OA; Mayerhofer M; Sperr WR; Esterbauer H; Valent P
J Allergy Clin Immunol; 2007 Jul; 120(1):192-9. PubMed ID: 17451799
[TBL] [Abstract][Full Text] [Related]
16. The detection of SRSF2 mutations in routinely processed bone marrow biopsies is useful in the diagnosis of chronic myelomonocytic leukemia.
Federmann B; Abele M; Rosero Cuesta DS; Vogel W; Boiocchi L; Kanz L; Quintanilla-Martinez L; Orazi A; Bonzheim I; Fend F
Hum Pathol; 2014 Dec; 45(12):2471-9. PubMed ID: 25305095
[TBL] [Abstract][Full Text] [Related]
17. Eosinophils are derived from the neoplastic clone in patients with systemic mastocytosis and eosinophilia.
Pardanani A; Reeder T; Li CY; Tefferi A
Leuk Res; 2003 Oct; 27(10):883-5. PubMed ID: 12860006
[TBL] [Abstract][Full Text] [Related]
18. Next-generation sequencing in systemic mastocytosis: Derivation of a mutation-augmented clinical prognostic model for survival.
Pardanani A; Lasho T; Elala Y; Wassie E; Finke C; Reichard KK; Chen D; Hanson CA; Ketterling RP; Tefferi A
Am J Hematol; 2016 Sep; 91(9):888-93. PubMed ID: 27214377
[TBL] [Abstract][Full Text] [Related]
19. When clinical heterogeneity exceeds genetic heterogeneity: thinking outside the genomic box in chronic myelomonocytic leukemia.
Ball M; List AF; Padron E
Blood; 2016 Nov; 128(20):2381-2387. PubMed ID: 27707735
[TBL] [Abstract][Full Text] [Related]
20. The KIT D816V expressed allele burden for diagnosis and disease monitoring of systemic mastocytosis.
Erben P; Schwaab J; Metzgeroth G; Horny HP; Jawhar M; Sotlar K; Fabarius A; Teichmann M; Schneider S; Ernst T; Müller MC; Giehl M; Marx A; Hartmann K; Hochhaus A; Hofmann WK; Cross NC; Reiter A
Ann Hematol; 2014 Jan; 93(1):81-8. PubMed ID: 24281161
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
